Initial dosage regimens of vancomycin for Chinese adult patients based on population pharmacokinetic analysis

被引:27
|
作者
Deng, Chenhui [1 ,2 ]
Liu, Taotao [3 ]
Zhou, Tianyan [1 ,2 ]
Lu, Hua [3 ]
Cheng, Daohai [3 ]
Zhong, Xiaobing [3 ]
Lu, Wei [1 ,2 ]
机构
[1] Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China
[2] Peking Univ, Sch Pharmaceut Sci, Beijing 100191, Peoples R China
[3] Guangxi Med Univ, Affiliated Hosp 1, Guangxi, Peoples R China
关键词
vancomycin; Chinese adult patients; population pharmacokinetics; NONMEM; steady-state trough concentrations; RESISTANT STAPHYLOCOCCUS-AUREUS; NEPHROTOXICITY; INFECTIONS; OUTCOMES;
D O I
10.5414/CP201842
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To build a population pharmacokinetic model for Chinese adult patients and develop initial dosage regimens for patients with different degrees of renal function to achieve target steady-state trough concentrations in the range of 10 - 15 and 15 - 20 mg/l. Method: Data on serum vancomycin concentration was collected from a retrospective study including 72 Chinese adult patients. NON-MEM was used to build the population pharmacokinetic model, and a one-compartment model was chosen to describe the vancomycin concentration-time profile. Internal evaluation by bootstrap and visual predictive check (VPC) was performed to evaluate the robustness and prediction of the final model. Monte Carlo simulations were conducted to develop initial dosage regimens to achieve target trough concentrations. Results: A one-compartment model was built with creatinine clearance (CLcr) as the key covariate influencing drug clearance. The estimated drug clearance for patients with normal renal function (CLcr >= 80 ml/min) was 4.90 1/h, and 0.0654 x CLcr if CLcr was < 80 ml/min. The apparent volume of the central compartment was 47.76 1 and no covariate was found to affect it. The results of bootstrap analysis were in agreement with the original parameters of the final model, and VPC of the final model demonstrated good predictability. Initial dosage regimens were developed based on the simulations of the population pharmacokinetic model. Conclusion: A one-compartment model fitted the retrospective data and CLcr had a significant effect on drug clearance. Initial dosage regimens for vancomycin were proposed to provide some help to individual therapy for Chinese adult patients with different renal functions.
引用
收藏
页码:407 / 415
页数:9
相关论文
共 50 条
  • [21] INDIVIDUALIZATION OF DIGOXIN DOSAGE REGIMENS BASED ON THE PHARMACOKINETIC SIMULATION
    HAYASHI, R
    SHIRAI, J
    TAKANO, T
    NISHIMOTO, Y
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1982, 46 (08): : 838 - 839
  • [22] Population pharmacokinetic analysis for dose regimen optimization of vancomycin in Southern Chinese children
    Shen, Xianhuan
    Li, Xuejuan
    Lu, Jieluan
    Zhu, Jiahao
    He, Yaodong
    Zhang, Zhou
    Chen, Zebin
    Zhang, Jianping
    Fan, Xiaomei
    Li, Wenzhou
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024, 13 (07): : 1201 - 1213
  • [23] Population Pharmacokinetic Analysis of Tacrolimus in Adult Chinese Patients with Myasthenia Gravis: A Prospective Study
    Liu, Jue
    Guo, Yun-Peng
    Jiao, Zheng
    Zhao, Chong-Bo
    Wu, Hui
    Li, Zi-Ran
    Cai, Xiao-Jun
    Xi, Jian-Ying
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2020, 45 (04) : 453 - 466
  • [24] Population Pharmacokinetic Analysis of Tacrolimus in Adult Chinese Patients with Myasthenia Gravis: A Prospective Study
    Jue Liu
    Yun-Peng Guo
    Zheng Jiao
    Chong-Bo Zhao
    Hui Wu
    Zi-Ran Li
    Xiao-Jun Cai
    Jian-Ying Xi
    European Journal of Drug Metabolism and Pharmacokinetics, 2020, 45 : 453 - 466
  • [25] Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population
    Duong, Alexandre
    El Gamal, Ahmed
    Bilodeau, Veronique
    Huot, Justine
    Delorme, Carole
    Poudrette, Johanne
    Crevier, Benoit
    Marsot, Amelie
    PHARMACOTHERAPY, 2024, 44 (06): : 425 - 434
  • [26] PHARMACOKINETIC COMPARISON OF 2 ALBENDAZOLE DOSAGE REGIMENS IN PATIENTS WITH NEUROCYSTICERCOSIS
    SANCHEZ, M
    SUASTEGUI, R
    GONZALEZESQUIVEL, D
    SOTELO, J
    JUNG, H
    CLINICAL NEUROPHARMACOLOGY, 1993, 16 (01) : 77 - 82
  • [27] Population Pharmacokinetic Modeling and Dose Optimization of Vancomycin in Chinese Patients with Augmented Renal Clearance
    Zhao, Sixuan
    He, Na
    Zhang, Yahui
    Wang, Chuhui
    Zhai, Suodi
    Zhang, Chao
    ANTIBIOTICS-BASEL, 2021, 10 (10):
  • [28] External validation of vancomycin population pharmacokinetic models in ten cohorts of infected Chinese patients
    Zhou, Ying
    Long, Enwu
    Shi, Tianlu
    Wang, Zhuo
    Zhao, Jun
    Liu, Hua
    Lin, Yang
    Jiang, Mingyan
    Lao, Haiyan
    Ge, Weihong
    Cui, Yimin
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2022, 30 : 163 - 172
  • [29] A Population Pharmacokinetic Model for Vancomycin in Adult Patients Receiving Extracorporeal Membrane Oxygenation Therapy
    Moore, J. N.
    Healy, J. R.
    Thoma, B. N.
    Peahota, M. M.
    Ahamadi, M.
    Schmidt, L.
    Cavarocchi, N. C.
    Kraft, W. K.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2016, 5 (09): : 495 - 502
  • [30] Vancomycin population pharmacokinetics and dosing proposal for the initial treatment in obese adult patients
    Polaskova, Lucie
    Murinova, Irena
    Gregorova, Jana
    Slanar, Ondrej
    Sima, Martin
    FRONTIERS IN PHARMACOLOGY, 2024, 15